Benchmark Maintains Speculative Buy on cbdMD, Lowers Price Target to $7

Benchmark maintains cbdMD (AMEX:YCBD) with a Speculative Buy and lowers the price target from $9 to $7.

Benzinga · 12/19/2019 12:45

Benchmark maintains cbdMD (AMEX:YCBD) with a Speculative Buy and lowers the price target from $9 to $7.